Delivery Order SPE2DB24D2101-SPE2DB25FKPEF
- Not listed
- The Defense Logistics Agency awarded a $1,583.17 delivery order to AmerisourceBergen Drug Corp for DOTAREM 10 MMOL/20 ML vials on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,048.20 on July 23, 2025, for the supply of Dotarem 10 mmol/20 mL vials. The contract is competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 24, 2025. This award is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical...
- This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dotarem 10 mmol/20 ml vials, a medical product. The contract has a ceiling value of $2,406.50 and is a delivery order with a firm fixed price. It is not a set-aside contract. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, identified as SPE2DX15D1022|SPE2DX24FVLTC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,543.80, is for the delivery of 4565385918 - DOTAREM 10 MMOL/20 ML VIAL 20ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. This award is a Firm Fixed Price Delivery Order contract type and does not have any set-aside designation....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,521.05 to AmerisourceBergen Drug Corp on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,288.33 to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and runs through December 2026. The delivery order will be...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,275.00 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 28, 2025, valued at $13,817.42 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside, competitively awarded delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,807.37 to AmerisourceBergen Drug Corp on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The delivery order will be fulfilled...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPEFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,563.40 to AmerisourceBergen Drug Corp for DOTAREM 10 mmol/20 ml vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for specialized medical supplies supporting federal healthcare needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive federal contract relationships with DLA and the Defense Health Agency, supplying a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive contracting positions it as a critical vendor within the military supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/4/25 |